Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
Neurotensin regulates both satiety and breast cancer growth in the experimental setting, but little is known about its role in the development of breast cancer or cardiometabolic disease in humans.
